• LAST PRICE
    11.8500
  • TODAY'S CHANGE (%)
    Trending Up0.6500 (5.8036%)
  • Bid / Lots
    8.0000/ 1
  • Ask / Lots
    13.0000/ 3
  • Open / Previous Close
    11.2600 / 11.2000
  • Day Range
    Low 11.0301
    High 12.0000
  • 52 Week Range
    Low 4.9500
    High 25.2100
  • Volume
    181,694
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 11.2
TimeVolumeFMTX
09:32 ET206211.5926
09:36 ET15011.2
09:38 ET38711.0301
09:50 ET51611.405
09:52 ET172611.51
09:54 ET146111.525
09:57 ET30011.59
09:59 ET20011.575
10:01 ET70011.6
10:08 ET30011.645
10:10 ET20011.645
10:15 ET293711.7
10:17 ET110011.76
10:19 ET120011.73
10:21 ET32511.785
10:24 ET70011.75
10:28 ET20011.73
10:30 ET10011.68
10:35 ET190211.69
10:37 ET32311.74
10:46 ET10011.76
10:51 ET20011.78
10:53 ET10011.88
10:57 ET1301611.92
11:00 ET10011.9
11:02 ET60011.89
11:06 ET30311.88
11:11 ET60011.83
11:13 ET104411.865
11:18 ET30011.83
11:20 ET20011.825
11:22 ET175811.83
11:24 ET10011.81
11:27 ET20011.78
11:36 ET10011.79
11:42 ET10011.7503
11:45 ET20011.75
11:47 ET103611.715
11:54 ET10011.71
11:58 ET10011.71
12:02 ET10011.64
12:03 ET40011.57
12:05 ET40011.61
12:07 ET10011.66
12:09 ET10011.67
12:18 ET10011.73
12:23 ET10011.74
12:30 ET40011.76
12:32 ET20011.79
12:36 ET10011.77
12:38 ET40211.75
12:39 ET10011.74
12:43 ET40011.76
12:48 ET10011.76
12:50 ET10011.77
12:52 ET10011.77
12:54 ET10011.73
01:03 ET10011.74
01:10 ET80311.79
01:14 ET10011.8
01:15 ET10011.79
01:17 ET10011.8
01:24 ET21011.805
01:26 ET13011.78
01:30 ET30011.79
01:44 ET62911.79
02:00 ET10011.82
02:02 ET30011.81
02:04 ET10011.79
02:06 ET20011.81
02:15 ET40011.8
02:18 ET10011.77
02:20 ET10011.77
02:22 ET314911.73
02:24 ET10011.76
02:26 ET40011.76
02:27 ET10011.79
02:29 ET30011.74
02:31 ET20011.73
02:33 ET40011.76
02:40 ET69211.79
02:44 ET10011.8025
02:45 ET28311.82
02:51 ET150011.82
02:54 ET133011.81
02:56 ET95111.82
03:02 ET31411.77
03:03 ET30011.78
03:05 ET70011.81
03:09 ET20011.81
03:12 ET30011.77
03:14 ET20011.79
03:16 ET170011.8
03:18 ET80011.81
03:20 ET10011.84
03:23 ET10011.83
03:25 ET163811.885
03:27 ET30011.88
03:30 ET132311.89
03:32 ET119611.86
03:34 ET60011.86
03:36 ET401911.85
03:38 ET110011.86
03:39 ET40011.83
03:41 ET116711.81
03:43 ET10011.78
03:45 ET20011.785
03:48 ET80011.795
03:50 ET76811.8
03:52 ET485011.85
03:54 ET256311.83
03:56 ET401911.86
03:57 ET324111.86
03:59 ET4658811.85
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesFMTX
Forma Therapeutics Holdings Inc
551.3M
-3.0x
---
United StatesAURA
Aura Biosciences Inc
558.3M
0.0x
---
United StatesVXRT
Vaxart Inc
564.2M
-5.6x
---
United StatesALT
Altimmune Inc
555.8M
-7.2x
---
United StatesRANI
Rani Therapeutics Holdings Inc
545.9M
-62.9x
---
United StatesJANX
Janux Therapeutics Inc
580.3M
-8.6x
---
As of 2022-08-13

Company Information

Forma Therapeutics Holdings, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapeutics for patients with hematologic diseases and cancers. Its pipeline consists of six product candidates. Its product candidates include etavopivat, FT-7051, Olutasidenib- Acute Myeloid Leukemia IDH1m inhibitor, and Olutasidenib Glioma IDH1m inhibitor. Its lead product candidate, etavopivat, is an oral, once-daily, potentially disease-modifying therapy for the treatment of sickle cell disease (SCD), and other hemoglobinopathies. Its product candidate, FT-7051, is an inhibitor of CREB-binding protein/E1A binding protein p300, or CBP/p300 for the treatment of metastatic castration-resistant prostate cancer (mCRPC). Olutasidenib is an oral, selective small molecule investigational agent designed to selectively bind to and inhibit mutated IDH1 enzymes.

Contact Information

Headquarters
300 North Beacon Street, Suite 501WATERTOWN, MA, United States 02472
Phone
617-679-1970
Fax
302-655-5049

Executives

Independent Chairman of the Board
Peter Wirth
President, Chief Executive Officer, Director
Frank Lee
Chief Financial Officer, Senior Vice President
Todd Shegog
Senior Vice President, Chief Human Resource Officer
Linea Aspesi
Chief Human Resource Officer, Senior Vice President - Corporate Affairs
Mary Wadlinger

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$551.3M
Revenue (TTM)
$0.00
Shares Outstanding
47.9M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-4.00
Book Value
$10.51
P/E Ratio
-3.0x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.